What is Vogelxo
TestosteroneThe Generic name of this drug
Treatment SummaryTestosterone is a hormone used to treat conditions where the body does not produce enough of the hormone naturally. It works by blocking the androgen receptor, which helps produce the male sex organs and other male sexual characteristics. Testosterone was first isolated from a sample in 1935 and then synthesized.
Androdermis the brand name
Vogelxo Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Androderm
Testosterone
1995
90
Approved as Treatment by the FDA
Testosterone, commonly known as Androderm, is approved by the FDA for 12 uses including Gonadotrophin releasing hormone deficiency and Hypogonadism .Gonadotrophin releasing hormone deficiency
Helps manage Gonadotrophin releasing hormone deficiency
Hypogonadism
Helps manage Idiopathic Hypogonadotropic Hypogonadism
Orchitis
Helps manage Orchitis
Hypergonadotropic Hypogonadism
Helps manage Hypergonadotropic Hypogonadism
Hypothalamo-pituitary disorder
Helps manage Hypothalamo-pituitary disorder
Hypogonadotropic hypogonadism
Breast
Used to treat inoperable, metastatic Breast cancer in combination with Testosterone enanthate
Orchidectomy
Helps manage Orchidectomy
1 to 5 years post-menopausal
Used to treat 1 to 5 years post-menopausal in combination with Testosterone enanthate
Puberty, Delayed
Used to treat Puberty, Delayed in combination with Testosterone enanthate
vanishing testis syndrome
Helps manage vanishing testis syndrome
Torsion of testis
Helps manage Torsion of testis
Effectiveness
How Vogelxo Affects PatientsTestosterone helps to form the sex organs and characteristics that are typically seen in men. How long it stays in the body can vary from person to person, with a typical half-life of 10-100 minutes. The amount of testosterone in an adult man's body usually ranges from 300-1000ng/dL, making it a relatively safe drug. It is important to caution patients about the potential for children to be exposed to testosterone when using topical products.
How Vogelxo works in the bodyThe androgen receptor is a protein that is found in the cytoplasm and binds to molecules like testosterone and dihydrotestosterone. Once bound, the androgen receptor changes shape and is transported to the nucleus. This allows it to bind to DNA and cause certain genes to be expressed. Testosterone and dihydrotestosterone are responsible for the formation of male sex organs, as well as secondary physical characteristics like facial and body hair, a deeper voice, and changes in muscle and fat distribution.
When to interrupt dosage
The quantity of Vogelxo is reliant upon the diagnosed disorder, like Gonadotrophin releasing hormone deficiency, Orchidectomy and Orchitis. The degree of dosage is contingent on the technique of delivery specified in the table beneath.Condition
Dosage
Administration
Orchidectomy
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Breast
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
1 to 5 years post-menopausal
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Hypogonadism
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
vanishing testis syndrome
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Orchitis
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Hypergonadotropic Hypogonadism
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Gonadotrophin releasing hormone deficiency
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Hypogonadotropic hypogonadism
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Puberty, Delayed
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Torsion of testis
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Hypothalamo-pituitary disorder
1.0 %, , 100.0 mg, 37.5 mg, 4.5 %, 50.0 mg, 200.0 mg, 5.5 mg, 0.1 mg/mg, 0.0125 mg/mg, 250.0 mg/mL, 12.5 mg, 0.05 mg/mg, 12.2 mg, 24.3 mg, 0.025 mg/mg, 100.0 mg/mL, 0.02025 mg/mg, 12.5 mg/pump actuation, 0.0405 mg/mg, 0.01 mg/mg, 0.00162 mg/mg, 75.0 mg, 30.0 mg/pump actuation, 0.0162 mg/mg, 0.2 mg/hour, 0.4 mg/hour, 30.0 mg/mL, 30.0 mg, 200.0 mg/mL, 87.5 mg, 25.0 mg, 40.0 mg, 0.03 mg/hour, 0.25 mg/hour, 0.5 mg/hour, 0.055 mg/mg, 60.0 mg
, Buccal, Patch - Transdermal, Oral, Topical, Solution, Gel, metered, Gel, metered - Topical, Transdermal, Nasal, Solution - Topical, Gel, Patch, Gel - Topical, Gel - Transdermal, Pellet, Intramuscular, Pellet - Oral, Tablet, Solution - Transdermal, Pellet - Subcutaneous, Gel - Nasal, Injection, solution - Intramuscular, Capsule - Oral, Tablet - Buccal, Injection - Intramuscular, Gel, metered - Transdermal, Suspension, Subcutaneous, Pellet, implantable - Subcutaneous, Pellet, implantable - Parenteral, Gel, metered - Nasal, Pellet, implantable, Parenteral, Suspension - Intramuscular, Capsule
Warnings
Vogelxo has two contraindications and should not be taken for the conditions illustrated in the following table.Vogelxo ContraindicationsCondition
Risk Level
Notes
Breast Cancer
Do Not Combine
suspected pregnancy
Do Not Combine
Common Vogelxo Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Testosterone.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Testosterone.
Alectinib
Major
The metabolism of Alectinib can be increased when combined with Testosterone.
Aminophylline
Major
The metabolism of Aminophylline can be increased when combined with Testosterone.
Astemizole
Major
The metabolism of Astemizole can be increased when combined with Testosterone.
Vogelxo Toxicity & Overdose RiskThere is limited information available on the effects of a testosterone product overdose. If an injectable product is overdosed on, the patient may suffer a stroke. Treatment for testosterone overdoses should involve ceasing the product, washing off any topical products, and providing supportive care.
Vogelxo Novel Uses: Which Conditions Have a Clinical Trial Featuring Vogelxo?
Ten active studies are examining the efficacy of Vogelxo in providing relief from Orchitis, Testicular Torsion and Hypothalamo-pituitary Dysfunctions.Condition
Clinical Trials
Trial Phases
Breast
0 Actively Recruiting
Gonadotrophin releasing hormone deficiency
2 Actively Recruiting
Phase 1
Hypogonadotropic hypogonadism
0 Actively Recruiting
Torsion of testis
0 Actively Recruiting
vanishing testis syndrome
0 Actively Recruiting
Orchitis
0 Actively Recruiting
Hypogonadism
8 Actively Recruiting
Phase 1, Phase 4, Phase 2
Orchidectomy
0 Actively Recruiting
Puberty, Delayed
1 Actively Recruiting
Phase 1
Hypothalamo-pituitary disorder
0 Actively Recruiting
1 to 5 years post-menopausal
0 Actively Recruiting
Hypergonadotropic Hypogonadism
0 Actively Recruiting
Vogelxo Reviews: What are patients saying about Vogelxo?
2.7Patient Review
9/18/2017 I had a lot of deep pimples while using this medication. They were below the surface of my skin and really hurt. The cream was also tacky and made my skin feel uncomfortable. I only gave it one star because I shouldn't have had a painful rash.
Patient Q&A Section about vogelxo
Is Vogelxo generic?
"No generic form of this product exists. Counterfeit versions of the drug sold by fraudulent online pharmacies may be unsafe." - Anonymous Online Contributor
Unverified Answer
How many doses in testosterone pump?
"The recommended dose for Vogelxo is 50 mg applied to clean, dry skin once a day. Your doctor may adjust your dose as needed, but the maximum recommended dose is 100 mg once a day." - Anonymous Online Contributor
Unverified Answer
How many grams of testosterone per pump?
"A metered-dose pump that delivers 20.25 mg of testosterone in 1.25 g of gel with each pump actuation." - Anonymous Online Contributor
Unverified Answer
Is Vogelxo a controlled substance?
"Under the Act, it is unlawful to knowingly or intentionally manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance.
Vogelxo contains testosterone, a substance that is regulated under the Controlled Substances Act. It is against the law to knowingly produce, distribute, or dispense this substance, or to possess it with the intent to do so." - Anonymous Online Contributor
Unverified Answer